GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (BSP:HYPE3) » Definitions » Cyclically Adjusted Revenue per Share

Hypera (BSP:HYPE3) Cyclically Adjusted Revenue per Share : R$8.71 (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Hypera Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Hypera's adjusted revenue per share for the three months ended in Dec. 2023 was R$2.897. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$8.71 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Hypera's average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Hypera was 6.90% per year. The lowest was 0.60% per year. And the median was 4.05% per year.

As of today (2024-04-28), Hypera's current stock price is R$28.55. Hypera's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was R$8.71. Hypera's Cyclically Adjusted PS Ratio of today is 3.28.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Hypera was 6.05. The lowest was 3.25. And the median was 4.57.


Hypera Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Hypera's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera Cyclically Adjusted Revenue per Share Chart

Hypera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.11 7.12 7.74 8.31 8.71

Hypera Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.31 8.48 8.59 8.67 8.71

Competitive Comparison of Hypera's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hypera's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hypera's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hypera's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hypera's Cyclically Adjusted PS Ratio falls into.



Hypera Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hypera's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.897/156.2729*156.2729
=2.897

Current CPI (Dec. 2023) = 156.2729.

Hypera Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 1.642 90.447 2.837
201406 1.757 91.838 2.990
201409 1.845 92.602 3.114
201412 -0.949 94.194 -1.574
201503 1.145 97.799 1.830
201506 1.125 100.006 1.758
201509 1.146 101.392 1.766
201512 1.176 104.247 1.763
201603 1.285 106.979 1.877
201606 1.255 108.851 1.802
201609 1.284 109.986 1.824
201612 1.222 110.802 1.723
201703 1.269 111.869 1.773
201706 1.303 112.115 1.816
201709 1.373 112.777 1.903
201712 1.544 114.068 2.115
201803 1.454 114.868 1.978
201806 1.441 117.038 1.924
201809 1.496 117.881 1.983
201812 1.424 118.340 1.880
201903 0.609 120.124 0.792
201906 1.518 120.977 1.961
201909 1.604 121.292 2.067
201912 1.380 123.436 1.747
202003 1.274 124.092 1.604
202006 1.643 123.557 2.078
202009 1.732 125.095 2.164
202012 1.693 129.012 2.051
202103 1.830 131.660 2.172
202106 2.357 133.871 2.751
202109 2.554 137.913 2.894
202112 2.543 141.992 2.799
202203 2.350 146.537 2.506
202206 2.963 149.784 3.091
202209 3.187 147.800 3.370
202212 3.307 150.207 3.441
202303 2.665 153.352 2.716
202306 3.491 154.519 3.531
202309 3.349 155.464 3.366
202312 2.897 156.273 2.897

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Hypera  (BSP:HYPE3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Hypera's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=28.55/8.71
=3.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Hypera was 6.05. The lowest was 3.25. And the median was 4.57.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Hypera Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Hypera's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hypera (BSP:HYPE3) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (BSP:HYPE3) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
Address
Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.

Hypera (BSP:HYPE3) Headlines

No Headlines